VYNE Therapeutics (VYNE) Other financing activities (2018 - 2021)
VYNE Therapeutics (VYNE) posted Other financing activities of $285000.0 for Q4 2021, up 2950.0% on a QoQ basis from -$10000.0 in Q3 2021, and up 122.66% year-over-year from $128000.0 in Q4 2020.
VYNE Therapeutics (VYNE) Other financing activities (2018 - 2021) Analysis & Trends
VYNE Therapeutics' Other financing activities history runs 4 years deep, the most recent figure standing at $285000.0 for Q4 2021.
- Quarterly Other financing activities rose 122.66% year-over-year to $285000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $522000.0 (up 68.39% YoY) and the FY2021 annual result came in at $522000.0, up 68.39% from the prior year.
- Other financing activities was $285000.0 for Q4 2021 at VYNE Therapeutics, up from -$10000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $376000.0 in Q1 2021 and bottomed at -$129000.0 in Q2 2021.
- A 4-year average of $118692.3 and a median of $82000.0 in 2020 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 775.0% in 2020, while the deepest fall reached 2100.0% in 2020.
- VYNE Therapeutics' Other financing activities stood at $346000.0 in 2018, then retreated by 7.23% to $321000.0 in 2019, then tumbled by 60.12% to $128000.0 in 2020, then surged by 122.66% to $285000.0 in 2021.
- Business Quant data shows VYNE's Other financing activities at $285000.0 in Q4 2021, -$10000.0 in Q3 2021, and -$129000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 285,000.00 |
| Dec 31, 2021 | 285,000.00 |
| Sep 30, 2021 | -10,000.00 |
| Sep 30, 2021 | -10,000.00 |
| Jun 30, 2021 | -129,000.00 |
| Jun 30, 2021 | -129,000.00 |
| Mar 31, 2021 | 376,000.00 |
| Mar 31, 2021 | 376,000.00 |
| Dec 31, 2020 | 128,000.00 |
| Dec 31, 2020 | 128,000.00 |
| Sep 30, 2020 | 82,000.00 |
| Sep 30, 2020 | 82,000.00 |
| Jun 30, 2020 | -40,000.00 |
| Jun 30, 2020 | -40,000.00 |
| Mar 31, 2020 | 140,000.00 |
| Mar 31, 2020 | 140,000.00 |
| Dec 31, 2019 | 321,000.00 |
| Dec 31, 2019 | 321,000.00 |
| Sep 30, 2019 | 26,000.00 |
| Sep 30, 2019 | 26,000.00 |